Driving impairment
This medicine may affect your ability to drive or use machines.
Leaflet ZOCAP 100mg capsules
- Product code:
- W69803011
- Quantity:
- 98
- Indicated for:
- epilepsy
- Route of administration:
- oral
- Substance:
- zonisamide (antiepileptic)
- ATC
- N03AX15 — Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Dizziness / vertigo
This medicine may cause dizziness or vertigo.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Suicidal ideation / mental changes
Seek medical help if suicidal thoughts or major behavior changes occur.
Drowsiness / sedation
This medicine may cause drowsiness or reduced alertness.
Zonisamide is an antiepileptic medication used to treat partial seizures, with or without secondary generalization, in patients with epilepsy. It is also sometimes used as an adjunct therapy for other types of epilepsy. Zonisamide works through multiple mechanisms, including blocking sodium and calcium channels, which reduces neuronal excitability and prevents seizures.
Zonisamide is indicated for both adults and children over the age of 6, typically as an adjunct therapy in cases where other antiepileptic drugs do not provide adequate seizure control. The medication is taken orally, and the dose is gradually adjusted to minimize the risk of side effects.
Common side effects include drowsiness, dizziness, nausea, loss of appetite, and weight loss. Rarely, more serious reactions such as metabolic acidosis, kidney stone formation, or severe allergic reactions may occur. Regular monitoring of kidney function and blood bicarbonate levels is important during treatment.
Zonisamide treatment should be administered under the supervision of a specialist, and patients must strictly follow the prescribed dosage. Abrupt discontinuation of the medication can lead to an increase in seizure frequency, so dose reduction should be done gradually, as directed by the doctor.
Zonisamide is indicated for both adults and children over the age of 6, typically as an adjunct therapy in cases where other antiepileptic drugs do not provide adequate seizure control. The medication is taken orally, and the dose is gradually adjusted to minimize the risk of side effects.
Common side effects include drowsiness, dizziness, nausea, loss of appetite, and weight loss. Rarely, more serious reactions such as metabolic acidosis, kidney stone formation, or severe allergic reactions may occur. Regular monitoring of kidney function and blood bicarbonate levels is important during treatment.
Zonisamide treatment should be administered under the supervision of a specialist, and patients must strictly follow the prescribed dosage. Abrupt discontinuation of the medication can lead to an increase in seizure frequency, so dose reduction should be done gradually, as directed by the doctor.
General data about ZOCAP 100mg
- Substance:
- zonisamide
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W69803011
- Concentration:
- 100mg
- Pharmaceutical form:
- capsules
- Quantity:
- 98
- Product type:
- Generic medicine
- Price:
- 411.39 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for zonisamide
Concentrations available for zonisamide
- 100mg
- 20mg/ml
- 25mg
- 50mg